FDA issued a Warning Letter to Jazz Pharmaceuticals, Inc on 10/11/2011 as a result of this inspection.
483 Jazz Pharmaceuticals May 2011

483 Jazz Pharmaceuticals May 2011

Daniel Roberts FDA$119.00 - Available Now

FDA investigators audited the Jazz Pharmaceuticals - Palo Alto, CA, United States facility and issued 3 inspectional observations (via FDA 483) on 06 May 2011.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 06 May 2011
  • Location: Palo Alto, United States
  • FEI: 3005615655
Add To Cart